“Phase II Multicenter Trial of Bevacizumab Plus Fluorouracil and Leucovorin in Patients with Advanced Refractory Colorectal Cancer: An NCI Treatment Referral Center Trial TRC-0301”, J Clin Oncol, vol. 24, pp. 3354-3360, 2006.
, “Clinical trails referral resource. Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab”, Oncology, vol. 15, pp. 1026-36, 2001.
,